Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (20)
  • 2024 (50)
  • 2023 (77)
  • 2022 (95)
  • 2021 (84)
  • 2020 (17)
  • 2019 (21)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (3710)
  • Synthetic drugs (976)
  • Guns/Weapons (907)
  • OCDETF/Task Force (706)
  • Fake Pills (562)
  • Arrests/Convictions - Major (524)
  • Guilty Plea (488)
  • Seizures (Drugs/Property) (414)
  • Overdose (298)
  • Major Law Enforcement Operation (245)
  • Diversion Division (222)
  • Take Back Day (217)
  • Task Forces/Task Force Officers (217)
  • Pharmaceuticals/Pharmacists/Physicians (214)
  • Gangs (182)
  • Money Laundering (182)
  • Outreach/Drug Prevention (149)
  • Fentanyl Awareness (124)
  • One Pill Can Kill (93)
  • HIDTA (92)
  • Press Conferences (65)
  • Public and Media Affairs - also see Congressional Affairs (48)
  • Prevention/Education - DEA websites GSAD, JTT etc (47)
  • Narcoterrorism (45)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (27)
  • International/Foreign Operations (26)
  • Red Ribbon (26)
  • Congressional Affairs (15)
  • Intergovernmental Affairs (9)
  • Terrorism (9)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (327)
  • Extraditions (45)

Drug Name

  • Oxycodone (73)
  • Fentanyl (60)
  • Opioids (57)
  • Cocaine (25)
  • Synthetic Opioids (21)
  • Hydromorphone (17)
  • Methamphetamine (17)
  • Benzodiazepines (13)
  • Heroin (13)
  • Morphine (10)
  • Amphetamines (8)
  • Methadone (5)
  • Marijuana (Cannabis) (4)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (37)
  • Sede (23)
  • New England (22)
  • Miami (20)
  • Seattle (20)
  • Dallas (19)
  • Atlanta (18)
  • Chicago (18)
  • New Jersey (17)
  • Houston (15)
  • El Paso (14)
  • San Francisco (14)
  • San Diego (10)
  • Los Angeles (7)
  • Omaha (7)
  • Phoenix (7)
  • New Orleans (6)
  • Louisville (5)
  • Rocky Mountain (5)
  • Detroit (2)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Newport News Pharmacy Agrees to Pay Civil Penalty under the Controlled Substances Act

Junio 21, 2022
NORFOLK, Va. – Hidenwood Pharmacy, Inc., located in Newport News, and its owner, Anne Hutchens, of Seaport, have agreed to pay $125,000 to settle civil penalty claims stemming from alleged record-keeping violations associated with controlled substances. The government alleged that the Hidenwood Pharmacy failed to comply with various recordkeeping requirements...
Junio 21, 2022
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Junio 16, 2022
Baltimore, Maryland – Norman Rosen, age 84, of Towson, Maryland, pleaded guilty today to conspiracy to distribute and dispense oxycodone in connection with his operation of Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., where he was Medical Director and part-owner. The guilty plea was announced by Jarod Forget, Special Agent...
Junio 16, 2022
PRESS RELEASE

Leader of Mexico’s United Cartels Extradited to U.S.

Junio 13, 2022
MIAMI – Adalberto Fructuoso Comparan-Rodriguez, a/k/a “Fruto,” the former mayor of Aguililla, Mexico and, according to the allegations, a leader of the United Cartels in Michoacán, Mexico, made his initial appearance in federal court in Miami, Florida today after his extradition from Guatemala. A South Florida grand jury returned an...
Junio 13, 2022
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

Junio 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
Junio 08, 2022
PRESS RELEASE

Collinsville Osteopathic Physician Admits Illegally Prescribing Drug

Junio 07, 2022
ST. LOUIS – An osteopathic physician from Collinsville, Illinois, pleaded guilty in U.S. District Court Tuesday and admitted illegally prescribing an anti-anxiety drug. Matthew Steven Miller, 43, pleaded guilty to one count of obtaining a controlled substance by fraud and one count of making a false statement concerning a health...
Junio 07, 2022
PRESS RELEASE

Newton Physician Resolves Allegations Of Improper Prescribing Practices Concerning Controlled Substances

Junio 03, 2022
BOSTON – Dr. Hooshang Poor, a Newton geriatric medicine physician, has agreed to pay $100,000 to resolve allegations that he prescribed controlled substances outside the usual course of professional practice, a violation of the Controlled Substances Act. Dr. Poor previously resolved allegations in February 2019 that he violated the False...
Junio 03, 2022
PRESS RELEASE

Two Men Indicted for International Conspiracy to Ship Fentanyl, Other Drugs into United States through Dark Web Connections

Junio 01, 2022
BRUNSWICK, GA: Two men from Canada and the United Kingdom have been indicted in the Southern District of Georgia on federal charges alleging an international operation used the Dark Web to distribute illegal drugs in the United States, with some of those drugs resulting in the deaths of two U.S...
Junio 01, 2022
PRESS RELEASE

Alleged Drug Trafficker Arraigned in Chicago After Extradition From Mexico

Mayo 27, 2022
CHICAGO — Robert Bell, Special Agent in Charge of U.S. Drug Enforcement Administration-Chicago Division, and U.S. Attorney John R. Lausch, Jr., for the Northern District of Illinois, announced that an alleged drug trafficker charged with distributing heroin in the Chicago area was arraigned today in federal court in Chicago after...
Mayo 27, 2022
PRESS RELEASE

Former Doctor Sentenced To 46 Months In Prison For Illegally Prescribing Controlled Substances

Mayo 27, 2022
TRUMBULL, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that DAVID CIANCIMINO, 63, of Trumbull, was sentenced today by U.S. District Judge Omar A. Williams in Hartford to 46 months of imprisonment, followed by three years of supervised release, for illegally distributing prescription medication...
Mayo 27, 2022
PRESS RELEASE

South Carolina Man Pleads Guilty to Distributing Illegal Steroids

Mayo 25, 2022
ABINGDON, Va. – The owner of a supplement company, that manufactured and shipped unapproved drugs and illegal steroids for use by members of the bodybuilding community, pled guilty this week to a pair of federal drug charges. John Franklin Cochcroft, 37, of Lexington, South Carolina, waived his right to be...
Mayo 25, 2022
Showing 191 - 200 of 372 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 16
  • Página 17
  • Página 18
  • Página 19
  • Current page 20
  • Página 21
  • Página 22
  • Página 23
  • Página 24
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español